LiveFeed
生物醫藥催化劑通知
即時動態將 FDA 更新、PDUFA 相關標題、臨床結果與公司新聞集中在同一資訊流,提供精確的美國東部時間與文章入口。
篩選
按精確股票代碼或關鍵字標籤篩選資訊流。 免費使用者可儲存 1 個股票代碼與 1 個關鍵字。
新聞標題由機器翻譯,詳情為英文原文。
2026/11/20 (星期五)
CAPR
Capricor Therapeutics Provides Regulatory Update on Deramiocel BLA for Duchenne Muscular DystrophyIOVA
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)TEVA
Teva to Present at the 9th Annual Evercore Healthcare Conference, the Piper Sandler 38th Annual Healthcare Conference and Citi’s 2026 Global Healthcare ConferencePLSE
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)ANTX
AN2 Therapeutics to Participate in 9th Annual Evercore Healthcare ConferenceSLS
SELLAS Life Sciences Announces Closing of Underwritten Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional SharesAVTX
Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)PMVP
PMV Pharmaceuticals Announces Promising Updated Data From the PYNNACLE Phase 2 Pivotal Trial of Rezatapopt Monotherapy in Patients With TP53 Y220C-Mutated Advanced Solid TumorsAPRE
Aprea Therapeutics Announces Interim Results From the Ongoing First-in-human Phase 1 Study of WEE1 Inhibitor APR-1051 in Patients with Advanced Solid Tumors (ACESOT-1051) at the 38th EORTC-NCI-AACR Symposium in BarcelonaPPBT
Purple Biotech's IM1240, a CAPTN-3-Capped Tri-Specific T- and NK-Cell Engager Targeting 5T4, Shows Robust Tumor Killing in Immunotherapy-Resistant Cancer Models in Plenary Oral Presentation at EORTC-NCI-AACR Symposium